000			04933 a2200349 4500
999			_c10767 _d10767
020			_a9780128206584
050			_aRC731 _bTAR 2020
100			_aDua, Kamal _eeditor
245	0	0	_aTargeting chronic inflammatory lung diseases using advanced drug delivery systems / _cedited by Kamal Dua, Philip M. Dansbro, Ridhima Wadhwa, Mehra Haghi, Lisa G. Pont and Kylie A. Williams
250			_a1.
264		1	_aWaltham : _bElsevier, _c2020.
300			_axxx, 587 pages : _billustrations
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index
505			_a1. Chronic respiratory diseases: An introduction and need for novel drug delivery approaches 2. Drug delivery of respiratory medicines in practice 3. Advanced drug delivery systems for respiratory diseases 4. Novel drug delivery systems and significance in respiratory diseases 5. Use of biologics in the treatment of asthma, COPD, ACOS, and idiopathic pulmonary fibrosis 6. Targeting biofilms in chronic respiratory infections using drug delivery systems 7. Absorption enhancement of macromolecule administered intrapulmonary 8. In silico analysis of drug delivery in respiratory disease 9. Concepts of nanotechnology in nanomedicine: From discovery to applications 10. Advancement in translational respiratory research using nanotechnology 11. Nanoparticle-based macromolecule drug delivery to lungs 12. Formulation and role of polymeric and inorganic nanoparticles in respiratory diseases 13. Inhalable hybrid nanocarriers for respiratory disorders 14. Functionalized nanoparticles in pulmonary disease diagnosis 15. Drug delivery system in pulmonary disease: Role of microparticles 16. Microparticulate drug delivery systems for targeting respiratory diseases 17. Porous particulate platforms for enhanced pulmonary delivery of bioactives 18. Liposomes in the treatment of chronic respiratory conditions 19. Theranostic drug delivery systems for targeted therapy of lung diseases 20. Targeted polymeric miceller systems for respiratory diseases 21. Hydrogels for pulmonary drug delivery 22. Mucoadhesive drug delivery systems in respiratory diseases 23. Targeting lung cancer using advanced drug delivery systems 24. Plant-based drug delivery systems in respiratory diseases 25. Role of essential oils in respiratory diseases through advanced and nanodrug delivery systems 26. Pharmacokinetics and pharmacodynamics of the advanced drug delivery systems
520			_aIntro -- Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems -- Copyright -- Dedication -- Contents -- Contributors -- Editors biography -- Chapter 1 Chronic respiratory diseases: An introduction and need for novel drug delivery approaches -- 1 Introduction -- 2 Lungs: Morphology and physiology -- 3 Overview of respiratory disease -- 3.1 Asthma -- 3.1.1 Treatments -- 3.2 Chronic obstructive pulmonary disease -- 3.3 Interstitial lung diseases -- 3.4 Cystic fibrosis -- 3.5 Tuberculosis -- 4 Lung cancer -- 4.1.1 Angiogenesis inhibitors -- 4.1.2 Insulin-like growth factor inhibitors -- 4.1.3 Histone deacetylase inhibitors -- 4.1.4 Proapopototic agents -- 5 Challenges of current therapeutic strategies -- 6 Summary and conclusion -- Conflict of interest -- Author contribution -- Funding -- References -- Chapter 2 Drug delivery of respiratory medicines in practice -- 1 Management of inflammatory lung disease in practice -- 1.1 Asthma -- 1.2 COPD -- 2 Drug delivery systems used in the management of chronic inflammatory pulmonary disease -- 3 Inhaler technique and device development -- References -- Chapter 3 Advanced drug delivery systems for respiratory diseases -- 1 Introduction -- 2 Pulmonary drug delivery devices -- 3 Advanced drug delivery systems -- 3.1 Microparticulate and nanoparticulate systems -- 3.2 Phage therapy -- 3.3 Oligonucleotide therapy -- 3.4 Gene delivery -- 4 Conclusion -- References -- Chapter 4 Novel drug delivery systems and significance in respiratory diseases -- 1 Introduction -- 2 Novel pulmonary drug delivery systems-An overview -- 2.1 Mechanisms for pulmonary drug administration -- 2.2 Strategic criteria for particle-based pulmonary delivery systems -- 2.3 General types of pulmonary drug delivery devices -- 3 Novel delivery systems targeting respiratory diseases -- 3.1 Nanoparticles
650			_aChronic diseases ; Treatment
650			_aChronic diseases Treatment
650			_aDrug Delivery Systems
650			_a Drug delivery systems
650			_aLungs ; Diseases ; Treatment
650			_aLungs Diseases Treatment
700	1		_aDua, Kamal, _eeditor.
700	1		_aHansbro, Phil, _eeditor.
700	1		_aHaghi, Mehra, _eeditor.
700	1		_aWadhwa, Ridhima, _eeditor.
700	1		_aPont, Lisa G. _eeditor
700	1		_aWilliams, Kylie A. _eeditor
942			_2lcc _cBK _h731 _iTAR _kRC